Clinical Trial Update: SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN [NA]

View source ↗

Summary

A clinical trial update indicates the SPYRAL AFFIRM Global Study evaluating renal denervation with the Symplicity Spyral system in subjects with uncontrolled hy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Chronic Kidney Disease
• Diabetes Mellitus
• Hypertension
• Vascular Diseases

Drugs mentioned

• Symplicity Spyral Renal Denervation System

Snippet

Sponsor: Medtronic Vascular | Conditions: Hypertension, Vascular Diseases | NA | Status: ACTIVE_NOT_RECRUITING